Rivelsa Kit
Pricing Report NDC 0093-6031-82

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Rivelsa (NDC 0093-6031-82) is $1.59320 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a a human prescription drug provided by Teva Pharmaceuticals Usa, Inc., this medication is distributed in a 2 POUCH in 1 CARTON / 1 KIT in 1 POUCH (0093-6031-91) configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.59320
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jun 17, 2026
Billable Units
2 EA
Estimated Package Price
$3.19
Data Status
As of Jul 08, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0093-6031-82
Description
2 POUCH in 1 CARTON / 1 KIT in 1 POUCH (0093-6031-91)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2024, the NADAC wholesale price for (NDC ) has moved within a range of $1.22383 to $1.93323 per EA. Over this 2 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.2238 - $1.9332
Market Volatility
57.97% Variance
Latest Trend
6.28%
Date Unit Price Unit Source Method Rate
Jun 17, 2026 $1.59320 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2026 $1.69998 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2025 $1.28029 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2025 $1.28029 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jul 23, 2025 $1.28502 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2025 $1.22383 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2025 $1.37013 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2025 $1.45076 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2025 $1.71548 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2025 $1.66356 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2025 $1.79743 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $1.74617 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2024 $1.93323 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2024 $1.74184 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 18, 2024 $1.67606 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 21, 2024 $1.55893 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 17, 2024 $1.59609 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 19, 2024 $1.80910 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 22, 2024 $1.73705 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 17, 2024 $1.90392 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026